N@N

Jay Olson Maintained (AMGN) at Buy with Decreased Target to $265 on, May 3rd, 2021

Jay Olson of Oppenheimer, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $275 to $265 on, May 3rd, 2021.

Jay has made no other calls on AMGN in the last 4 months.

There are 9 other peers that have a rating on AMGN. Out of the 9 peers that are also analyzing AMGN, 3 agree with Jay's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $230 on, Wednesday, April 28th, 2021
• Kennen MacKay of "RBC Capital" Maintained at Hold with Decreased Target to $217 on, Wednesday, April 28th, 2021
• Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $230 on, Friday, March 5th, 2021

These are the ratings of the 6 analyists that currently disagree with Jay

---

• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $278 on, Wednesday, April 28th, 2021
• Steve Chesney of "Atlantic Equities" Downgraded from Hold to Sell and Held Target at $200 on, Wednesday, April 28th, 2021
• Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $259 on, Wednesday, April 28th, 2021
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $260 on, Wednesday, February 3rd, 2021
• Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $265 on, Wednesday, February 3rd, 2021
• Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $295 on, Wednesday, February 3rd, 2021

Contributing Sources

---